Identification of a major pathogenic epitope in the human IRBP molecule recognized by mice of the H-2r haplotype - PubMed (original) (raw)

Affiliations

PMID: 7706044

Identification of a major pathogenic epitope in the human IRBP molecule recognized by mice of the H-2r haplotype

P B Silver et al. Invest Ophthalmol Vis Sci. 1995 Apr.

Abstract

Purpose: Mice of the H-2b, H-2k, and H-2r haplotypes develop experimental autoimmune uveoretinitis (EAU) after immunization with interphotoreceptor retinoid-binding protein (IRBP) of bovine or monkey origin. The purpose of this study was to identify putative pathogenic epitope(s) of IRBP and to establish their immunodominance within the IRBP molecule.

Methods: Overlapping 20-amino acid peptides, spanning the entire human IRBP molecule, were synthesized and used to immunize C57BL/10 (H-2b), B10.BR (H-2k), and B10.RIII (H-2r) mice. Bovine IRBP was used as a positive control. Experimental autoimmune uveoretinitis was examined by histopathology 21 days after immunization. Immunologic responses were assessed by delayed-type hypersensitivity (DH) and lymphocyte proliferation assays.

Results: Peptide 161-180, spanning the sequence SGIPYIISYLHPGNTILHVD, was found to be highly pathogenic for B10.RIII mice but not for the other strains. A dose-response curve showed that peptide 161-180 was maximally pathogenic at 50 micrograms, but incidence and scores were reduced at 10 micrograms. The truncated 13-mer 165-177 was also highly pathogenic (100 to 200 micrograms), suggesting that it contained the pathogenic epitope. Mice immunized with the peptide, or with whole IRBP, had positive DH and lymphocyte responses to the immunizing as well as to the reciprocal antigen. A cell line derived to peptide 161-180 was also pathogenic for B10.RIII mice after adoptive transfer and responded (proliferation) to native IRBP.

Conclusions: High incidence and high severity scores, as well as immunologic cross-recognition of peptide 161-180 and native IRBP in vivo and in vitro, suggest that this peptide contains a major epitope recognized as pathogenic by B10.RIII mice.

PubMed Disclaimer

Cited by

Injection of an alpha-melanocyte stimulating hormone expression plasmid is effective in suppressing experimental autoimmune uveitis.
Lee DJ, Biros DJ, Taylor AW. Lee DJ, et al. Int Immunopharmacol. 2009 Aug;9(9):1079-86. doi: 10.1016/j.intimp.2009.05.001. Epub 2009 May 6. Int Immunopharmacol. 2009. PMID: 19426838 Free PMC article.
CD4+CD25+ T regulatory cells induced by LPS-activated bone marrow dendritic cells suppress experimental autoimmune uveoretinitis in vivo.
Siepmann K, Biester S, Plsková J, Muckersie E, Duncan L, Forrester JV. Siepmann K, et al. Graefes Arch Clin Exp Ophthalmol. 2007 Feb;245(2):221-9. doi: 10.1007/s00417-006-0356-9. Graefes Arch Clin Exp Ophthalmol. 2007. PMID: 16741709
Characterization of a New Epitope of IRBP That Induces Moderate to Severe Uveoretinitis in Mice With H-2b Haplotype.
Mattapallil MJ, Silver PB, Cortes LM, St Leger AJ, Jittayasothorn Y, Kielczewski JL, Moon JJ, Chan CC, Caspi RR. Mattapallil MJ, et al. Invest Ophthalmol Vis Sci. 2015 Aug;56(9):5439-49. doi: 10.1167/iovs.15-17280. Invest Ophthalmol Vis Sci. 2015. PMID: 26284549 Free PMC article.
Optimization of determinant factors associated with the efficiency of experimental autoimmune uveitis induction in C57BL/6 mice.
Yang M, Yang Z, Huang J, Yu W, He X, Yuan M, Han W, Chen W. Yang M, et al. Ann Transl Med. 2022 Dec;10(23):1274. doi: 10.21037/atm-22-2293. Ann Transl Med. 2022. PMID: 36618787 Free PMC article.
Sequence 168 to 177 of interphotoreceptor retinoid-binding protein (IRBP) is an antigenic epitope for autoreactive CD8 T cells in the B10RIII mouse.
Song L, Le J, Ye F, Shao H, Kaplan HJ, Sun D. Song L, et al. J Neuroimmunol. 2008 Jan;193(1-2):68-76. doi: 10.1016/j.jneuroim.2007.10.016. Epub 2007 Dec 11. J Neuroimmunol. 2008. PMID: 18063114 Free PMC article.

Identification of a major pathogenic epitope in the human IRBP molecule recognized by mice of the H-2r haplotype - PubMed (original) (raw)